CatalystWireBeta

Hvivo

HVO · AIM · Health Care · mcap £41m · 6.0p

Beta Briefing, track record and signals & risks are not ready for Hvivo yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26
Source: results 15 Sep 26 ↗
Revenue
£38.9m
Operating profit
−£11.0m
Net income
−£12.2m
Free cash flow
−£10.8m
Net cash
£13.0m
Market cap
£41.7m
EV / EBIT
–
FCF yield
−26.0%
Price / book
1.3×
Latest half-year · H1 26 vs H1 25 results 15 Sep 26 ↗
Revenue
£16.3m
−33%
Operating profit
−£6.9m
prior −£550k
Net income
−£6.5m
prior −£236k
Cash from operations
£322k
prior −£7.5m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Half-year Results, published 15 Sep 26 · read the announcement ↗

As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note